Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-05-29 | 2021-02-25 | 116156 |
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2020-05-29 | 2020-06-04 | 116159 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2020-05-29 | 2020-07-23 | 116162 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-05-29 | 2020-07-09 | 116165 |
TEVA-QUININE | 300MG | CAPSULE | Resolved | 2020-05-29 | 2020-07-23 | 116168 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2020-06-04 | 2020-06-11 | 116666 |
TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116669 |
TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116672 |
TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-06-04 | 2020-07-09 | 116675 |
TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116678 |
TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-06-04 | 2020-06-25 | 116681 |
TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-06-04 | 2020-07-09 | 116684 |
TEVA-CARVEDILOL | 12.5MG | TABLET | Resolved | 2020-06-04 | 2020-09-25 | 116687 |
TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-06-04 | 2020-08-21 | 116690 |
TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116693 |
TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-06-04 | 2020-06-11 | 116696 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116699 |
ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Resolved | 2020-06-11 | 2023-10-03 | 117593 |
TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2020-06-18 | 2020-07-23 | 118244 |
TEVA-MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-18 | 2020-10-22 | 118247 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |